These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1744684)

  • 61. Carboplatin and etoposide for recurrent malignant glioma: one department's experience.
    Stein ME; Tzuk-Shina Z; Ravkin A; Drumea K; Goldsher D
    Am J Clin Oncol; 1998 Apr; 21(2):215-6. PubMed ID: 9537216
    [No Abstract]   [Full Text] [Related]  

  • 62. Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas.
    van den Bent MJ; Schellens JH; Vecht CJ; Sillevis Smit PA; Loosveld OJ; Ma J; Tijssen CC; Jansen RL; Kros JM; Verweij J
    Eur J Cancer; 1998 Sep; 34(10):1570-4. PubMed ID: 9893630
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study.
    Jeremic B; Shibamoto Y; Grujicic D; Milicic B; Stojanovic M; Nikolic N; Dagovic A; Aleksandrovic J
    Radiother Oncol; 1999 Apr; 51(1):27-33. PubMed ID: 10386714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
    Walter AW; Gajjar A; Ochs JS; Langston JW; Sanford RA; Kun LE; Heideman R
    Med Pediatr Oncol; 1998 Jan; 30(1):28-33. PubMed ID: 9371386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. "Eight-drugs-in-one-day" chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas.
    Rozental JM; Robins HI; Finlay J; Healey B; Levin AB; Steeves RA; Kohler PC; Schutta HS; Trump DL
    Cancer; 1989 Jun; 63(12):2475-81. PubMed ID: 2720598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
    Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
    Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Chemoradiotherapies for malignant gliomas].
    Aoki T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():472-7. PubMed ID: 16201566
    [No Abstract]   [Full Text] [Related]  

  • 68. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
    Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
    Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
    J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.
    Mack F; Schäfer N; Kebir S; Stuplich M; Schaub C; Niessen M; Scheffler B; Herrlinger U; Glas M
    Oncology; 2014; 86(5-6):369-72. PubMed ID: 24942787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
    Bardet E; Rivière A; Charloux A; Spaeth D; Ducoloné A; Le Groumellec A; Pellae-Cosset B; Henry-Amar M; Douillard JY
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):163-8. PubMed ID: 9212019
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials.
    Espinoza JC; Haley K; Patel N; Dhall G; Gardner S; Allen J; Torkildson J; Cornelius A; Rassekh R; Bedros A; Etzl M; Garvin J; Pradhan K; Corbett R; Sullivan M; McGowage G; Stein D; Jasty R; Sands SA; Ji L; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2016 Oct; 63(10):1806-13. PubMed ID: 27332770
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Molecular Mechanisms of Plant-Derived Compounds Targeting Brain Cancer.
    Fan HC; Chi CS; Chang YK; Tung MC; Lin SZ; Harn HJ
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385679
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression.
    Tsai CF; Yeh WL; Chen JH; Lin C; Huang SS; Lu DY
    Int J Mol Sci; 2014 Mar; 15(3):3889-903. PubMed ID: 24599080
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sepia ink oligopeptide induces apoptosis in prostate cancer cell lines via caspase-3 activation and elevation of Bax/Bcl-2 ratio.
    Huang F; Yang Z; Yu D; Wang J; Li R; Ding G
    Mar Drugs; 2012 Oct; 10(10):2153-2165. PubMed ID: 23170075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas.
    Harn HJ; Lin SZ; Lin PC; Liu CY; Liu PY; Chang LF; Yen SY; Hsieh DK; Liu FC; Tai DF; Chiou TW
    Neuro Oncol; 2011 Jun; 13(6):635-48. PubMed ID: 21565841
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Which therapy works better in choroid plexus carcinomas?
    Berrak SG; Liu DD; Wrede B; Wolff JE
    J Neurooncol; 2011 May; 103(1):155-62. PubMed ID: 20976614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.